USE OF HUMAN CHORIONIC GONADOTROPIN TO INHIBIT DEVELOPMENT OR MINIMIZE SEVERITY OF CEREBRAL PALSY AND/OR ITS CO-MORBIDITIES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 26, 2015
app pub date -
Jan 23, 2014
filing date -
Jan 25, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The invention described herein relates generally to the use of human chorionic gonadotropin (hCG) or a subunit or variant thereof, in neurodevelopmental disorders. In particular, the present invention relates to the use of hCG and related compounds as described herein for treating or reducing the likelihood of cerebral palsy and its co-morbidities in a patient or subject including a neonate, an infant or a child.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully